A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma

NCT00661336 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study was withdrawn due to lack of patients.

Conditions

Melanoma (Skin)

Interventions

DRUG: buthionine sulfoximine
DRUG: melphalan
GENETIC: microarray analysis
OTHER: high performance liquid chromatography
OTHER: laboratory biomarker analysis
OTHER: pharmacological study
PROCEDURE: biopsy

Sponsor

Duke University

Collaborators

[object Object]